CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
Taking everything into account, CRBN scores 6 out of 10 in our fundamental rating. CRBN was compared to 62 industry peers in the Chemicals industry. CRBN scores excellent on profitability, but there are some minor concerns on its financial health. CRBN may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, CRBN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
CRBN had a positive operating cash flow in the past year.
CRBN had positive earnings in each of the past 5 years.
Each year in the past 5 years CRBN had a positive operating cash flow.
1.2 Ratios
CRBN has a better Return On Assets (12.43%) than 100.00% of its industry peers.
CRBN has a better Return On Equity (24.88%) than 96.77% of its industry peers.
CRBN has a Return On Invested Capital of 6.89%. This is in the better half of the industry: CRBN outperforms 77.42% of its industry peers.
CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 6.15%.
The last Return On Invested Capital (6.89%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROIC | 6.89% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN's Profit Margin of 14.92% is amongst the best of the industry. CRBN outperforms 93.55% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
The Operating Margin of CRBN (7.04%) is better than 67.74% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a Gross Margin (24.81%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CRBN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
The debt/assets ratio for CRBN has been reduced compared to a year ago.
2.2 Solvency
CRBN has an Altman-Z score of 2.56. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
CRBN has a better Altman-Z score (2.56) than 66.13% of its industry peers.
The Debt to FCF ratio of CRBN is 5.10, which is a neutral value as it means it would take CRBN, 5.10 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.10, CRBN is doing good in the industry, outperforming 74.19% of the companies in the same industry.
CRBN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, CRBN is in line with its industry, outperforming 56.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.06
WACC6.48%
2.3 Liquidity
A Current Ratio of 1.17 indicates that CRBN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, CRBN is doing worse than 77.42% of the companies in the same industry.
A Quick Ratio of 0.58 indicates that CRBN may have some problems paying its short term obligations.
With a Quick ratio value of 0.58, CRBN is not doing good in the industry: 87.10% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 168.39% over the past year.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 1.90% in the last year.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
3.2 Future
The Earnings Per Share is expected to grow by 27.50% on average over the next years. This is a very strong growth
CRBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.97% yearly.
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.71, the valuation of CRBN can be described as very cheap.
Based on the Price/Earnings ratio, CRBN is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
CRBN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.98.
Based on the Price/Forward Earnings ratio of 11.87, the valuation of CRBN can be described as reasonable.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaper than 82.26% of the companies in the same industry.
CRBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than the industry average as 66.13% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 80.65% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.82 | ||
| EV/EBITDA | 8.71 |
4.3 Compensation for Growth
CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)0.1
PEG (5Y)0.12
EPS Next 2Y34.31%
EPS Next 3Y27.5%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.50%, CRBN has a reasonable but not impressive dividend return.
CRBN's Dividend Yield is a higher than the industry average which is at 3.07.
CRBN's Dividend Yield is a higher than the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
21.80% of the earnings are spent on dividend by CRBN. This is a low number and sustainable payout ratio.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.8%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
AMS:CRBN (4/29/2025, 5:29:50 PM)
18.565
-0.07 (-0.4%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners77.4%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts78.46
Price Target26.08 (40.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP21.8%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.79%
PT rev (3m)-5.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.41%
EPS NY rev (3m)3.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.93%
Revenue NY rev (3m)-1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 | ||
| P/S | 0.84 | ||
| P/FCF | 10.82 | ||
| P/OCF | 5.87 | ||
| P/B | 1.4 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 8.71 |
EPS(TTM)3.25
EY17.51%
EPS(NY)1.56
Fwd EY8.42%
FCF(TTM)1.72
FCFY9.24%
OCF(TTM)3.16
OCFY17.02%
SpS22.11
BVpS13.26
TBVpS11.56
PEG (NY)0.1
PEG (5Y)0.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROCE | 8.18% | ||
| ROIC | 6.89% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 7.95% | ||
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% | ||
| FCFM | 7.76% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 97% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 3.61 | ||
| Cash Conversion | 103.72% | ||
| Profit Quality | 51.98% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.56 |
F-Score8
WACC6.48%
ROIC/WACC1.06
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year147.92%
EBIT Next 3Y43.91%
EBIT Next 5YN/A
FCF growth 1Y520.5%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y11.31%
OCF growth 3Y101.81%
OCF growth 5Y9.98%